Genewity B.V.
Arno Bisschop is a Co-founder and CEO at Genewity B.V., where Arno works on a data platform for consultancy firms to navigate upcoming SFDR and EU Taxonomy regulations. Arno also holds advisory roles at Quantitas Solutions, 414, and plnktn. Previously, Arno served as Chief Medical Officer at Triall and Founder of Stichting Medical Business. Arno has a strong background in health sciences, with degrees in Management, Policy-Analysis, Entrepreneurship, Honours in Medicine, and Biomedical Sciences from Vrije Universiteit Amsterdam.
This person is not in any teams
This person is not in any offices
Genewity B.V.
Genewity B.V. is a recently founded biotech company based in Leiden, the Netherlands. Closely collaborating with the LUmc, we build on successes of our scientific and business teams in cell and gene therapies, including the first multi-centric clinical trial for gene therapy in the EU (the RAG1 SCID trial). Genewity has been founded to commercialize another potentially groundbreaking therapy for developing autologous thymus tissue de novo. Genewity is currently in a preclinical development stage and is engaged in raising a Series A to push the technology to the clinic.